Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s DiseaseDavid Henley, Gary Romano, Rema Raman et al.|New England Journal of Medicine|2019Cited by 200
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa A. Sperling, Gary Romano, David Henley et al.|JAMA Neurology|2021Cited by 110